27821359|t|Pupillary response abnormalities in depressive disorders
27821359|a|Depressive disorders lack objective physiological measurements to characterize the affected population and facilitate study of relevant mechanisms. The melanopsin - mediated light signaling pathway may contribute to seasonal variation and can be measured non-invasively by pupillometry. We prospectively studied changes in melanopsin - mediated pupillary constriction in 19 participants with major depressive disorder (MDD) and 10 control across the summer and winter solstices. The melanopsin - mediated response, as measured by the pupil's sustained constriction six s after a high intensity blue light stimulus, was marginally attenuated in those with MDD relative to controls (p =0.071). The participants with MDD unexpectedly showed a significantly reduced transient pupillary response to low intensity red (p =0.011) and blue light (p =0.013), but not high intensity red and blue light. Sustained pupillary constriction in response to high intensity blue light was more pronounced with increasing daylight hours (p =0.037) and was more strongly related to objectively measured versus estimated light exposure. Melanopsin - mediated impairments in pupil response may serve as a biological marker for vulnerability to depression in low light conditions. Assessment of these and other responses to light stimuli, such as response to low intensity light, may be useful for the study of the neurobiology of MDD and related mood disorders.
27821359	0	18	Pupillary response	T040	C4067879
27821359	19	32	abnormalities	T033	C1704258
27821359	36	56	depressive disorders	T048	C0011581
27821359	57	77	Depressive disorders	T048	C0011581
27821359	78	82	lack	T080	C0332268
27821359	83	92	objective	T080	C1571702
27821359	93	106	physiological	T169	C0205463
27821359	107	119	measurements	T169	C0242485
27821359	123	135	characterize	T052	C1880022
27821359	140	159	affected population	T201	C4285581
27821359	175	180	study	T062	C0008972
27821359	184	192	relevant	T080	C2347946
27821359	193	203	mechanisms	T169	C0441712
27821359	209	219	melanopsin	T116	C0670514
27821359	222	230	mediated	T041	C0870868
27821359	231	254	light signaling pathway	T044	C0037080
27821359	273	291	seasonal variation	T079	C0036496
27821359	303	311	measured	T080	C0444706
27821359	330	342	pupillometry	T060	C0260180
27821359	347	368	prospectively studied	T062	C0033522
27821359	380	390	melanopsin	T116	C0670514
27821359	393	401	mediated	T041	C0870868
27821359	402	424	pupillary constriction	T042	C3537108
27821359	431	443	participants	T101	C0030705
27821359	449	474	major depressive disorder	T048	C1269683
27821359	476	479	MDD	T048	C1269683
27821359	488	495	control	T096	C0009932
27821359	507	534	summer and winter solstices	T079	C1254367
27821359	540	550	melanopsin	T116	C0670514
27821359	553	570	mediated response	T041	C0870868
27821359	575	583	measured	T080	C0444706
27821359	591	621	pupil's sustained constriction	T033	C0728710
27821359	636	650	high intensity	UnknownType	C0683109
27821359	651	661	blue light	T070	C0303896
27821359	662	670	stimulus	T067	C0234402
27821359	687	697	attenuated	T052	C0599946
27821359	712	715	MDD	T048	C1269683
27821359	728	736	controls	T096	C0009932
27821359	738	739	p	T081	C1709380
27821359	753	765	participants	T101	C0030705
27821359	771	774	MDD	T048	C1269683
27821359	797	810	significantly	T078	C0750502
27821359	811	818	reduced	T080	C0392756
27821359	819	828	transient	T079	C0205374
27821359	829	847	pupillary response	T040	C4067879
27821359	851	864	low intensity	UnknownType	C0683108
27821359	865	868	red	T070	C0563227
27821359	870	871	p	T081	C1709380
27821359	884	894	blue light	T070	C0303896
27821359	896	897	p	T081	C1709380
27821359	915	929	high intensity	UnknownType	C0683109
27821359	930	933	red	T070	C0563227
27821359	938	948	blue light	T070	C0303896
27821359	960	982	pupillary constriction	T042	C3537108
27821359	986	994	response	T040	C4067879
27821359	998	1012	high intensity	UnknownType	C0683109
27821359	1013	1023	blue light	T070	C0303896
27821359	1049	1059	increasing	T169	C0442808
27821359	1060	1068	daylight	T070	C0023693
27821359	1069	1074	hours	T079	C0439227
27821359	1076	1077	p	T081	C1709380
27821359	1119	1130	objectively	T080	C1571702
27821359	1131	1139	measured	T080	C0444706
27821359	1147	1156	estimated	T081	C0750572
27821359	1157	1171	light exposure	T051	C1689916
27821359	1173	1183	Melanopsin	T116	C0670514
27821359	1186	1194	mediated	T041	C0870868
27821359	1195	1206	impairments	T169	C0221099
27821359	1210	1224	pupil response	T040	C4067879
27821359	1240	1257	biological marker	T201	C0005516
27821359	1262	1275	vulnerability	T033	C1821973
27821359	1279	1289	depression	T048	C0011570
27821359	1293	1302	low light	UnknownType	C0683108
27821359	1303	1313	conditions	T080	C0348080
27821359	1315	1325	Assessment	T058	C0220825
27821359	1345	1354	responses	T032	C0871261
27821359	1358	1363	light	T070	C0023693
27821359	1364	1371	stimuli	T067	C0234402
27821359	1381	1389	response	T032	C0871261
27821359	1393	1412	low intensity light	UnknownType	C0683108
27821359	1436	1441	study	T062	C0008972
27821359	1449	1461	neurobiology	T091	C0027817
27821359	1465	1468	MDD	T048	C1269683
27821359	1481	1495	mood disorders	T048	C0525045